Evidence map›Paper›PMID 11302797›Full record

ArticleAntimicrobial agents and chemotherapy2001

Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5.

D M Rothstein, P Spacciapoli, L T Tran, T Xu, F D Roberts, M Dalla Serra, D K Buxton, F G Oppenheim, P Friden

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 183 citations in OpenAlex.

  1. Review
  2. From decay to discovery: A new antimicrobial peptide from Chrysomya megacephala (Diptera: Calliphoridae) larvae.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  3. Article
  4. Article
  5. Structure, biosynthesis, and bioactivity of nostolysamides.bioRxiv : the preprint server for biology · 2026
    Article
  6. Review
  7. Modifying Antifungal Peptides as Safe Food Preservatives.Journal of agricultural and food chemistry · 2025
    Article
  8. Article
  9. Article
  10. Exploring the Healing Powers of Histatins: From Oral Health to Therapeutics.International journal of molecular sciences · 2025
    Review
  11. Article
  12. Microorganisms · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Secreted Aspartic Proteinases: Key Factors inInternational journal of molecular sciences · 2024
    Review
  19. Article
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

D M RothsteinPeriodontix, Inc., Watertown, Massachusetts, USA. drothstein@rcn.com
P Spacciapoli
L T Tran
T Xu
F D Roberts
M Dalla Serra
D K Buxton
F G Oppenheim
P Friden
Boston University · US

Funding

MICROBICIDAL SALIVARY HISTIDINE-RICH PROTEINSR01DE007652 · NIDCR · BOSTON UNIVERSITY MEDICAL CAMPUS · PI OPPENHEIM, FRANK G · 1986 to 2012
$3.9M
NIDCR NIH HHS DE 07652
6 · The paper itself

Abstract

Through the analysis of a series of 25 peptides composed of various portions of the histatin 5 sequence, we have identified P-113, a 12-amino-acid fragment of histatin 5, as the smallest fragment that retains anticandidal activity comparable to that of the parent compound. Amidation of the P-113 C terminus increased the anticandidal activity of P-113 approximately twofold. The three histidine residues could be exchanged for three hydrophobic residues, with the fragment retaining anticandidal activity. However, the change of two or more of the five basic (lysine and arginine) residues to uncharged residues resulted in a substantial loss of anticandidal activity. A synthetic D-amino-acid analogue, P-113D, was as active against Candida albicans as the L-amino-acid form. In vitro MIC tests in low-ionic-strength medium showed that P-113 has potent activity against Candida albicans, Candida glabrata, Candida parapsilosis, and Candida tropicalis. These results identify P-113 as a potential antimicrobial agent in the treatment of oral candidiasis.

Indexed as

Amino Acid SequenceAntifungal AgentsCandida albicansDrug Resistance, MicrobialHistatinsHumansMicrobial Sensitivity TestsMolecular Sequence DataPeptide FragmentsSalivary Proteins and PeptidesSaralasinSequence Homology, Amino AcidAntifungal AgentsHistatinsHTN3 protein, humanPeptide FragmentsSalivary Proteins and PeptidesSaralasin

Identifiers

PMID11302797
PMCPMC90475
OpenAlexW2096630634

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.